Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002563269 | SCV001692085 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2023-08-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377837 | SCV002686649 | likely benign | Cardiovascular phenotype | 2021-12-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002495732 | SCV002798600 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1; Catecholaminergic polymorphic ventricular tachycardia 2 | 2021-11-16 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003346580 | SCV004050792 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700757 | SCV001923393 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001700757 | SCV001954636 | likely benign | not provided | no assertion criteria provided | clinical testing |